Deflazacort

Deflazacort (trade name Calcort among others) is a glucocorticoid used as an anti-inflammatory and immunosuppressant. It was patented in 1965 and approved for medical use in 1985. The U.S. Food and Drug Administration (FDA) considers it to be a first-in-class medication for Duchenne muscular dystrophy.

Deflazacort

Deflazacort (trade name Calcort among others) is a glucocorticoid used as an anti-inflammatory and immunosuppressant. It was patented in 1965 and approved for medical use in 1985. The U.S. Food and Drug Administration (FDA) considers it to be a first-in-class medication for Duchenne muscular dystrophy.